Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagan Muppidi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Protocols in Immunology|April 25, 2008
Measurement of apoptosis and other forms of cell deathJagan Muppidi, Melissa Porter, Richard M Siegel
Immunologic Research|July 15, 2003
Death receptor signaling and autoimmunityRichard M Siegel, Jagan Muppidi, Margaret Roberts, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated DegradationLin Zhang, Arnold Bolomsky, Omar S Al-Odat, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Cancer Cell|March 1, 2024
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patientsAndrea J Radtke, Ekaterina Postovalova, Arina Varlamova, et al.
The New England Journal of Medicine|June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell LymphomaChristopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Protocols in Immunology|April 25, 2008
Measurement of apoptosis and other forms of cell deathJagan Muppidi, Melissa Porter, Richard M Siegel
Immunologic Research|July 15, 2003
Death receptor signaling and autoimmunityRichard M Siegel, Jagan Muppidi, Margaret Roberts, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated DegradationLin Zhang, Arnold Bolomsky, Omar S Al-Odat, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.
Cancer Cell|March 1, 2024
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patientsAndrea J Radtke, Ekaterina Postovalova, Arina Varlamova, et al.
The New England Journal of Medicine|June 20, 2024
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell LymphomaChristopher Melani, Rahul Lakhotia, Stefania Pittaluga, et al.
Pageof 1